FLGT - フルジェント・ジェネティクス (Fulgent Genetics Inc.) フルジェント・ジェネティクス

 FLGTのチャート


 FLGTの企業情報

symbol FLGT
会社名 Fulgent Genetics Inc (フルジェント・ジェネティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical Specialities  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 フルゲント・ジェネティクス(Fulgent Genetics Inc)は患者治療の質を改善する臨床的に使用可能な診断情報を医者に提供する遺伝子検査を提供する技術会社である。同社はデータ比較・抑制アルゴリズム、適合学習ソフトウェア、先端的遺伝子診断ツール及び統合試験所プロセスを統合する技術プラットフォームを開発した。同社の遺伝子プローブは新規遺伝子をテスト・メニューに組み込み、疾患特異的検査の新パネルを開発し、顧客のために検査をカスタマイズすることを可能とするソフトウェア用に最適化された遺伝的データを生み出すように設計される。   フルジェント・ジェネティクスは米国のバイオテクノロジ―企業。患者ケアの質向上のため、幅広い遺伝子テストを医師に提供。同社の専有技術プラットフォ―ムを開発、遺伝子テストの項目を増やし、より正確で所要時間の短縮を図りながら、価格帯を抑えることを可能にする。本社はカリフォルニア州テンプル・シティ―。   
本社所在地 4978 Santa Anita Avenue Temple City CA 91780 USA
代表者氏名 Ming Hsieh Ming Hsieh
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 626-350-0537
設立年月日 42491
市場名 NASDAQ National Market System
ipoyear 2016年
従業員数 98人
url www.fulgentgenetics.com
nasdaq_url https://www.nasdaq.com/symbol/flgt
adr_tso
EBITDA EBITDA(百万ドル) -4.75700
終値(lastsale) 3.97
時価総額(marketcap) 71537411.03
時価総額 時価総額(百万ドル) 65.05039
売上高 売上高(百万ドル) 18.83700
企業価値(EV) 企業価値(EV)(百万ドル) 34.44739
当期純利益 当期純利益(百万ドル) -5.65400
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Fulgent Genetics Inc revenues increased 1% to $10.1M. Net loss totaled $3M vs. income of $207K. Revenues reflect United States segment increase of 33% to $5.8M Other Countries segment increase of 65% to $2.1M. Net loss reflects Research and development increase of 74% to $2.4M (expense) Selling and marketing increase of 35% to $2.2M (expense).

 FLGTのテクニカル分析


 FLGTのニュース

   88 Biggest Movers From Friday  2021/02/01 09:07:57 Benzinga
Gainers Siebert Financial Corp. (NASDAQ: SIEB ) shares climbed 121.6% to close at $8.22 on Friday on heavy volume. Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB ) climbed 70.8% to close at $4.15 after the company announced the acquisition of Quellis Biosciences. GameStop Corp. (NYSE: GME ) shares added 67.9% to close at $325.00 after Robinhood said it would allow some buying of the stocks on Friday after sparking outrage over discontinuing purchases of GME, AMC, and high stocks seeing social media interest. The company’s stock dropped over 44% on Thursday. Novavax, Inc. (NASDAQ: NVAX ) surged 64.9% to close at $220.94 after the company said Thursday that its COVID-19 vaccine candidate NVX-COV2373 showed 89.3% efficacy in Phase 3 trials conducted in the United Kingdom. AMC Entertainment Holdings, Inc. (NYSE: AMC ) surged 53.7% to close at $13.26 after Robinhood said it would allow some buying of the stocks on Friday after sparking outrage over discontinuing purchases of GME, AMC, and high stocks seeing social media interest.
   Oppenheimer Stick to Their Buy Rating for Fulgent Genetics Inc By Investing.com  2021/01/31 23:25:01 Investing.com
Oppenheimer Stick to Their Buy Rating for Fulgent Genetics Inc
   The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO  2021/01/28 13:03:49 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 27) Abbott Laboratories (NYSE: ABT ) (reacted to fourth-quarter results) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) Atea Pharmaceuticals Inc (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) Aziyo Biologics Inc (NASDAQ: AZYO ) Cassava Sciences Inc (NASDAQ: SAVA ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Collplant Biotechnologies Ltd – ADR (NASDAQ: CLGN ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) Frequency Therapeutics Inc (NASDAQ: FREQ ) (reacted to ratings upgrade by JPMorgan to Overweight) Fulgent Genetics Inc (NASDAQ: FLGT ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Illumina, Inc. (NASDAQ: ILMN ) ImmuCell Corporation (NASDAQ: ICCC ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Kaleido Biosciences Inc (NASDAQ: KLDO ) LeMaitre Vascular Inc (NASDAQ: LMAT ) Ligand Pharmaceuticals Inc. (NASDAQ: LGND ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) Nantkwest Inc (NASDAQ: NK ) Penumbra Inc (NYSE: PEN ) Regulus Therapeutics Inc (NASDAQ: RGLS ) Rubius Therapeutics Inc (NASDAQ: RUBY ) Silence Therapeutics ADR Representing 3 Ord Shs (NASDAQ: SLN ) Summit Therapeutics Inc (NASDAQ: SMMT ) Supernus Pharmaceuticals Inc (NASDAQ: SUPN ) Tenax Therapeutics Inc (NASDAQ: TENX ) Vanda Pharmaceuticals Inc.
   Fulgent Genetics to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference  2021/01/06 13:00:00 GlobeNewswire
TEMPLE CITY, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company…
   Oppenheimer Stick to Their Buy Rating for Fulgent Genetics Inc  2020/12/31 07:25:00 Investing.com
Oppenheimer Stick to Their Buy Rating for Fulgent Genetics Inc
   Fulgent Genetics, Inc. (NASDAQ:FLGT) Expected to Post Quarterly Sales of $51.73 Million  2020/10/22 18:44:48 The Olympia Report
Analysts predict that Fulgent Genetics, Inc. (NASDAQ:FLGT) will report $51.73 million in sales for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Fulgent Genetics’ earnings, with the lowest sales estimate coming in at $49.95 million and the highest estimate coming in at $53.50 million. Fulgent Genetics reported sales of $10.35 […]
   Fulgent Genetics (NASDAQ:FLGT) Stock Rating Lowered by BidaskClub  2020/10/21 06:06:43 Zolmax News
Fulgent Genetics (NASDAQ:FLGT) was downgraded by stock analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Monday, BidAskClub reports. Other research analysts have also issued research reports about the stock. Oppenheimer reiterated a “buy” rating and issued a $75.00 price objective on shares of Fulgent Genetics in a […]
   Cramer Advises Viewers On Peloton, Vale And More  2020/09/18 13:01:35 Benzinga
On CNBC's "Mad Money Lightning Round," Jim Cramer said NextEra Energy Inc (NYSE: NEE ) is the fastest-growing growth utility. If you want a growth utility that is the one. Cramer likes Peloton Interactive Inc (NASDAQ: PTON ), but it has runway up too high. He thinks it could trade even higher, but he doesn't like the risk-reward. Fulgent Genetics Inc (NASDAQ: FLGT ) … Full story available on Benzinga.com
   Precipio, AnPac Bio-Medical Science leads the gainers pack, Cardiff Oncology, Fulgent Genetics amongst major losers  2020/09/04 15:04:09 Seeking Alpha
Gainers: Precipio (NASDAQ:PRPO) +15%, AnPac Bio-Medical Science Co ANPC +15%, The Cooper Companies (NYSE:COO) +7%, Entasis Therapeutics Holdings (NASDAQ:ET
   Fulgent Shares Up 10% On COVID-19 Testing Deal For New York Schools  2020/09/03 01:25:15 Benzinga
Fulgent Genetics (NASDAQ: FLGT ) shares spiked nearly 10% in the after-hours session Wednesday, as the company said it would supply COVID-19 testing to hundreds of thousands of students in partnership with New York City Health and Hospitals at nearly 1,600 locations. What Happened: The California-based company will supply its RT-PCR at-home test, approved under United States Federal Drug Administration emergency use authorization, for students, as they return to … Full story available on Benzinga.com
   The Daily Biotech Pulse: Adcom Rules In Favor Of Mesoblast, CureVac IPO, Novavax Clinches UK COVID-19 Vaccine Deal  2020/08/14 12:26:21 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 13) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Fulgent Genetics Inc (NASDAQ: FLGT ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Inozyme Pharma Inc (NASDAQ: INZY ) iTeos Therapeutics Inc (NASDAQ: ITOS ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Natera Inc (NASDAQ: NTRA ) Nurix Therapeutics Inc (NASDAQ: NRIX ) Orthopediatrics Corp (NASDAQ: KIDS ) Penumbra Inc (NYSE: PEN ) Rocket Pharmaceuticals Inc (NASDAQ: RCKT ) Silk Road Medical Inc (NASDAQ: SILK ) TFF Pharmaceuticals Inc (NASDAQ: TFFP ) Vaxcyte Inc (NASDAQ: PCVX ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 13) Entera Bio Ltd (NASDAQ: ENTX ) Forma Therapeutics Holdings Inc (NASDAQ: FMTX )(reacted to its second-quarter results) Lantern Pharma Inc. (NASDAQ: LTRN ) NanoVibronix Inc (NASDAQ: NAOV ) Recro Pharma Inc (NASDAQ: REPH ) Stocks In Focus Novavax Agrees to Supply 60M Doses of Coronavirus Vaccine to U.K. Novavax, Inc. (NASDAQ: NVAX ) said it has signed a term sheet with the U.K. for supplying 60 million doses of NVX-CoV2373, its COVID-19 vaccine candidate.
   The Daily Biotech Pulse: Regulatory Setback For Fennec Pharma, Ligand To Buy Pfenex, Inovio Says Phase 2/3 Coronavirus Vaccine Study Starts In September  2020/08/11 12:20:27 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Allovir Inc (NASDAQ: ALVR ) BioLife Solutions Inc (NASDAQ: BLFS ) BioSpecifics Technologies Corp. (NASDAQ: BSTC ) (reacted to second-quarter results) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Fulgent Genetics Inc (NASDAQ: FLGT ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Inari Medical Inc (NASDAQ: NARI ) Kura Oncology Inc (NASDAQ: KURA ) Omeros Corporation (NASDAQ: OMER ) ( announced positive results for the study of its lead asset in COVID-19) Pacira Biosciences Inc (NASDAQ: PCRX ) RedHill Biopharma Ltd (NASDAQ: RDHL ) Rocket Pharmaceuticals Inc (NASDAQ: RCKT ) Seres Therapeutics Inc (NASDAQ: MCRB ) ( reacted to positive late-stage clinical readout) Silk Road Medical Inc (NASDAQ: SILK ) Sorrento Therapeutics Inc (NASDAQ: SRNE ) Trevena Inc (NASDAQ: TRVN ) (announced FDA nod for pain drug) Unity Biotechnology Inc (NASDAQ: UBX ) Vaxcyte Inc (NASDAQ: PCVX ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 10) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI ) (went public Friday) Freeline Therapeutics Holdings plc ADS (NASDAQ: FRLN ) (went public Friday) Lantern Pharma Inc. (NASDAQ: LTRN ) Nkarta Inc (NASDAQ: NKTX ) Recro Pharma Inc (NASDAQ: REPH ) (reacted to second-quarter results) Stocks In Focus Equillium Announces Positive Interim Data For Lead Drug, Requests Pre-IND Meeting For COVID-19 Study Equillium Inc (NASDAQ: EQ ) announced positive interim data from the first two cohorts of the Phase 1b open label, dose escalation portion of the EQUATE study of itolizumab in acute graft-versus-host disease.
   54 Stocks Moving in Wednesday's Pre-Market Session  2020/08/05 11:43:20 Benzinga
Gainers Valaris plc (NYSE: VAL ) shares rose 64.9% to $0.6502 in pre-market trading after gaining around 4% on Tuesday. Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO ) rose 51.5% to $2.00 in pre-market trading after the company announced a second clinical trial with funding from the MTEC to evaluate Razuprotafib for the prevention and treatment of ARDS in patients with moderate to severe coronavirus. Marathon Patent Group, Inc. (NASDAQ: MARA ) shares rose 29.3% to $4.28 in pre-market trading after dropping 14% on Tuesday. Marathon Patent, last week, reported the purchase of 700 M31S+ ASIC minders and shipment of 660 S-19 Pro Bitmain Miners. Whiting Petroleum Corporation (NYSE: WLL ) rose 26.9% to $1.37 in pre-market trading after surging more than 40% on Tuesday. Biofrontera AG (NASDAQ: BFRA ) rose 24.8% to $6.99 in pre-market trading. Acorda Therapeutics, Inc. (NASDAQ: ACOR ) rose 21.9% to $0.78 in pre-market trading after the company reported better-than-expected Q2 results. U.S. Energy Corp. (NASDAQ: USEG ) rose 21.8% to $6.53 in pre-market trading.
   The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings  2020/08/05 11:35:15 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) ABIOMED, Inc. (NASDAQ: ABMD ) (FDA approved the emergency use of Abiomed's Impella heart pump in combination with an oxygen machine to treat Covid-19 patients who suffer heart and lung failure) Allovir Inc (NASDAQ: ALVR ) (IPOed Thursday) Alterity Therapeutics Ltd (NASDAQ: ATHE ) ( announced positive preclinical data for its lead drug in Multiple System Atrophy) ALX Oncology Holdings Inc (NASDAQ: ALXO ) Cardiff Oncology Inc (NASDAQ: CRDF ) Cocrystal Pharma Inc (NASDAQ: COCP ) (announced the publication of positive preclinical animal studies of coronavirus antiviral compounds in a medical journal) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Fulgent Genetics Inc (NASDAQ: FLGT ) Hologic, Inc. (NASDAQ: HOLX ) Inari Medical Inc (NASDAQ: NARI ) Inozyme Pharma Inc (NASDAQ: INZY ) Quidel Corporation (NASDAQ: QDEL ) Renalytix AI PLC (NASDAQ: RNLX ) Sorrento Therapeutics Inc (NASDAQ: SRNE ) Trevena Inc (NASDAQ: TRVN ) Twist Bioscience Corp (NASDAQ: TWST ) Varian Medical Systems, Inc. (NYSE: VAR ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 4) Pandion Therapeutics Holdco LLC (NASDAQ: PAND ) Verrica Pharmaceuticals Inc (NASDAQ: VRCA ) Stocks In Focus Novavax Announces Positive Phase 1 Data For Coronavirus Vaccine Novavax, Inc. (NASDAQ: NVAX ) announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID 19 vaccine NVX CoV2373 with and without Matrix M adjuvant, which showed the investigational vaccine was generally well-tolerated and elicited robust antibody responses numerically superior to that seen in human convalescent sera.
   The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More  2020/07/29 11:32:01 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Capricor Therapeutics Inc (NASDAQ: CAPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Medpace Holdings Inc (NASDAQ: MEDP ) (saw an extension of its earnings-induced momentum) NeoGenomics, Inc. (NASDAQ: NEO )(reacted to its second-quarter results) OncoSec Medical Inc (NASDAQ: ONCS ) Penumbra Inc (NYSE: PEN ) Qiagen NV (NYSE: QGEN ) TFF Pharmaceuticals Inc (NASDAQ: TFFP ) Trevena Inc (NASDAQ: TRVN ) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 28) Nkarta Inc (NASDAQ: NKTX ) Nurix Therapeutics Inc (NASDAQ: NRIX )(IPOed Friday) Verrica Pharmaceuticals Inc (NASDAQ: VRCA ) Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN ) Stocks In Focus Alector Slips After Presenting Dementia Drug Trial Results Alector Inc (NASDAQ: ALEC ) announced at the virtual 2020 Alzheimer's Association International Conference, or AAIC, preliminary results from a Phase 1b and open-label Phase 2 studies of AL001 for the treatment of people with frontotemporal dementia with a progranulin gene mutation, or FTD-GRN, with the Phase 1 study showing AL001 was generally safe and well-tolerated.

 関連キーワード  (先端医療機器_テクノロジ― 米国株 フルジェント・ジェネティクス FLGT Fulgent Genetics Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)